PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
142.24%
Net income growth above 1.5x CRK's 62.92%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
-4.31%
Negative yoy D&A while CRK is 4.16%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
2466.67%
Well above CRK's 82.49% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
-13.64%
Negative yoy SBC while CRK is 20.81%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
183.80%
Well above CRK's 168.14% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
183.80%
Lower 'other working capital' growth vs. CRK's 1640.25%. David Dodd would see fewer unexpected short-term demands on cash.
-12.28%
Negative yoy while CRK is 51.71%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-18.66%
Negative yoy CFO while CRK is 14.42%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-9.59%
Negative yoy CapEx while CRK is 47.41%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-2816.67%
Negative yoy acquisition while CRK stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-112.13%
Negative yoy purchasing while CRK stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
1373.68%
Liquidation growth of 1373.68% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-52.56%
We reduce yoy other investing while CRK is 0.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-233.86%
We reduce yoy invests while CRK stands at 47.41%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
68.51%
Debt repayment growth of 68.51% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.